Additional file 7: of Monitoring Src status after dasatinib treatment in HER2+ breast cancer with 89Zr-trastuzumab PET imaging

2018-10-25T05:00:00Z (GMT) by Brooke McKnight Nerissa Viola-Villegas
Table S4. 89Zr-trastuzumab tumor VOI, pSrc (416) densitometry, and pHER2 (Y1221/1222) densitometry values for BT-474. (JPG 64 kb)